Abstract
Nanotechnology has been explored for its prospective to deliver bioactives in potentially safer concentrations through both passive and active targeting. Inorganic nanomaterials particularly gold nanoparticles find tremendous applications in biomedicine. In this review, common synthesis techniques and biofunctionalization strategies and areas of applications for gold nanoparticles are discussed. Gold nanoparticles can be considered as advanced platforms for combined therapeutic and diagonostic applications due to their unique physicochemical properties including large specific surface area, adaptability to surface modification, biocompatibility and stability. Further they possess photothermal and radiosensitization characteristics. Gold nanoparticles possess unique properties in terms of their use in drug delivery, therapeutic, biodiagonostics and imaging applications.
Keywords: Gold nanoparticles, imaging, photothermal, cancer, drug delivery, targeting.
Graphical Abstract
Pharmaceutical Nanotechnology
Title:Gold Nanoparticles as Carrier(s) for Drug Targeting and Imaging
Volume: 3 Issue: 3
Author(s): Satish Shilpi and Kapil Khatri
Affiliation:
Keywords: Gold nanoparticles, imaging, photothermal, cancer, drug delivery, targeting.
Abstract: Nanotechnology has been explored for its prospective to deliver bioactives in potentially safer concentrations through both passive and active targeting. Inorganic nanomaterials particularly gold nanoparticles find tremendous applications in biomedicine. In this review, common synthesis techniques and biofunctionalization strategies and areas of applications for gold nanoparticles are discussed. Gold nanoparticles can be considered as advanced platforms for combined therapeutic and diagonostic applications due to their unique physicochemical properties including large specific surface area, adaptability to surface modification, biocompatibility and stability. Further they possess photothermal and radiosensitization characteristics. Gold nanoparticles possess unique properties in terms of their use in drug delivery, therapeutic, biodiagonostics and imaging applications.
Export Options
About this article
Cite this article as:
Shilpi Satish and Khatri Kapil, Gold Nanoparticles as Carrier(s) for Drug Targeting and Imaging, Pharmaceutical Nanotechnology 2015; 3 (3) . https://dx.doi.org/10.2174/2211738504666151127192830
DOI https://dx.doi.org/10.2174/2211738504666151127192830 |
Print ISSN 2211-7385 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacogenetics of Irinotecan
Current Medicinal Chemistry - Anti-Cancer Agents Receptor-Independent Effects of Endocannabinoids on Ion Channels
Current Pharmaceutical Design Exploring Optic Nerve Axon Regeneration
Current Neuropharmacology Channel-Like Functions of the 18-kDa Translocator Protein (TSPO): Regulation of Apoptosis and Steroidogenesis as Part of the Host-Defense Response
Current Pharmaceutical Design The Diversity of Epithelial Secreted Mucins
Current Organic Chemistry Pyruvate Kinase M2: Regulatory Circuits and Potential for Therapeutic Intervention
Current Pharmaceutical Design Protective Effects of Curcumin against Iron-induced Toxicity
Current Pharmaceutical Biotechnology Diffuse Large B-Cell Lymphoma Presenting as an Anterior Chest Wall Mass: A Case Report and Literature Review
Current Respiratory Medicine Reviews Realizing the Potential of Blueberry as Natural Inhibitor of Metastasis and Powerful Apoptosis Inducer: Tapping the Treasure Trove for Effective Regulation of Cell Signaling Pathways
Anti-Cancer Agents in Medicinal Chemistry An Overview on COVID-19 and its Effect on Cardiovascular Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Preparation and Primary Bioevaluation of 99mTc-labeled-1-thio-β-D-Glucose as Melanoma Targeting Agent
Current Radiopharmaceuticals Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Current Pharmaceutical Design Microfluidic approaches to synchrotron radiation-based Fourier transform infrared (SR-FTIR) spectral microscopy of living biosystems
Protein & Peptide Letters The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Some Wild-Growing Plant Species from Serbia and Montenegro as the Potential Sources of Drugs
Current Pharmaceutical Design Compartmentalized Platforms for Neuro-Pharmacological Research
Current Neuropharmacology β-Carboline Alkaloids: Biochemical and Pharmacological Functions
Current Medicinal Chemistry TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design 3-Substituted Isocoumarins as Thymidine Phosphorylase Inhibitors
Letters in Drug Design & Discovery